Open Your FREE Demat Account Now!

Looks Health Services Ltd. Share Price

NSE
BSE

BSE : 534422

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹

High

₹

Price Summary

Previous Close ₹7.85
Day's Range ₹7.84 - ₹8.70
Open ₹7.84
52 Week Range ₹03.57 - ₹11.01
Volume 1,242
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 0.10
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 358.37
TTM EPS (₹) 0.02
P/E Ratio 295.98
Book Value(₹) 0.56
PAT Margin (%) 6.06
Face Value (₹) 10.00
ROCE(%) 0.22

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 0.7 3.95
Expenses N/A N/A
PBT 0.02 0.29
Operating profit 0.0 0.0
Net profit 0.02 0.24

Shareholding Pattern

Promoters (% Holding)

0.00%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

83.01%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

16.99%

About Looks Health Services Ltd.

Founded 2011
Managing Director Monika Joshi

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,18,204.09 1,743.00 1,583.70 - 1,583.70
Divi's Laboratories Ltd. 2,38,496.97 8,984.00 5,647.50 - 5,647.50
Torrent Pharmaceuticals Ltd. 1,70,480.87 4,482.00 3,532.60 - 3,532.60
Zydus Lifesciences Ltd. 1,12,503.47 1,127.85 835.50 - 835.50
Apollo Hospitals Enterprise Ltd. 1,11,173.58 7,731.95 6,696.50 - 6,696.50
Lenskart Solutions Ltd. 1,08,802.30 630.00 0.00 - 0.00
Cipla Ltd. 1,08,012.30 1,337.00 1,165.70 - 1,165.70
Laurus Labs Ltd. 1,06,657.63 1,974.00 902.35 - 902.35
Dr. Reddy's Laboratories Ltd. 1,02,206.60 1,224.50 1,101.00 - 1,101.00
Mankind Pharma Ltd. 91,572.10 2,217.00 1,909.70 - 1,909.70
no-content No Records Found

Latest News

Aug
4
2026
EQUITY Posted on Aug 4th 2026

Looks Health Services informs about outcome of board meeting

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Looks Health Services has informed that the Board of Directors of the Company in its meeting held today on Tuesday, 4th August, 2026 at the Registered Office of the Company has considered and approved following businesses: Un‐audited Financial Results and Limited Review Report (issued by KPSJ Associates & LLP, Statutory Auditors) for the quarter ended 30th June, 2026 is enclosed. Further, as per the Company's Code of Conduct for Prohibition of Insider Trading, the Trading Window is already closed from 01st July, 2026 and will remain close till completion of 48 hours of declaration of the Unaudited Financial Results of the Company for the quarter ended 30th June, 2026, on such information being made public for all Directors, KMPs Designated Employees and Connected Persons of the Company as defined in the Code. The board meeting commenced at 02:45 PM and concluded at 03:15 PM.

The above information is a part of company’s filings submitted to BSE.
Read More
Oct
23
2026
EQUITY Posted on Oct 23rd 2026

Kilitch Drugs (India) informs about press release

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Kilitch Drugs (India) has informed that it enclosed a Press Release relating to the proposed divestment of entire stake in the overseas subsidiary which the company shall be releasing immediately after intimation to the exchanges.

The above information is a part of company’s filings submitted to BSE.

Read More
Oct
23
2026
EQUITY Posted on Oct 23rd 2026

Concord Biotech submits analyst meet intimation

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, read with Para A of Schedule III thereto, Concord Biotech has informed that the Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the unaudited Standalone and Consolidated Financial Results of the Company for the second quarter and half year ended on September 30, 2026, scheduled on Wednesday, October 28, 2026 at 3:30 PM IST. The Earnings Call invite is enclosed for records. The conference/Earning Call Invitation is enclosed.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
23
2026
EQUITY Posted on Oct 23rd 2026

Glenmark Pharmaceuticals submits board meeting intimation

Glenmark Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on Thursday, November 5, 2026, to consider and approve the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026. Further noted that the notice of the aforesaid meeting is also being made available on the website of the Company in terms of Regulation 46(2) of the SEBI LODR. The Unaudited Financial Results of the Company shall be submitted to the Stock Exchanges after the conclusion of the aforesaid Board Meeting on Thursday, November 5, 2026, and will also be hosted on the website of the Company on the said date and thereafter shall be published in the newspapers, in accordance with the SEBI LODR. Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, and Company’s Code of Conduct for Prevention of Insider Trading, the Company has already informed the Stock Exchanges vide its letter dated September 28, 2026 that the window for trading in securities of the Company for the Designated Persons viz, Directors, Key Managerial Personnel, Identified Employees / Persons of the Company including the Immediate Relatives of the Designated Persons and the Connected Persons, etc. would remain closed from October 01, 2026 till the expiry of 48 hours after the declaration of Unaudited Financial results for the quarter and half year ended September 30, 2026 and accordingly, the trading window shall remain closed till Saturday, November 07, 2026 and shall re-open thereafter, i.e. on Sunday, November 08, 2026. 
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
23
2026
EQUITY Posted on Oct 23rd 2026

Park Medi World informs about disclosure

In continuation to its previous disclosure dated October 14, 2026, Park Medi World has informed that verification has been conducted by the Income Tax Department from October 12, 2026 to October 17, 2026, at some of the premises inter-alia related to the Company, some of its subsidiaries and officials. The details as required under the Listing Regulations read with SEBI circular HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated January 30, 2026, are provided in ‘Annexure’ as enclosed. The disclosure is also being disseminated on the Company's website at https://www.parkhospital.in/. 

The above information is a part of company’s filings submitted to BSE.

Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Looks Health Services Ltd. ?

The current share price of Looks Health Services Ltd. is ₹7.85 as of 2026-10-23.

The market capitalisation of Looks Health Services Ltd. is ₹8.24 as of 2026-10-23.

The 1-year return of Looks Health Services Ltd. is 2.85% as of 2026-10-23.

The P/E ratio of Looks Health Services Ltd. is 295.98 as of 2026-10-24.

The 52-week high and low of Looks Health Services Ltd. are ₹11.01 and ₹3.57, respectively, as of 2026-10-23.

The dividend yield of Looks Health Services Ltd. is 0.0% as of2026-10-23.

You can buy Looks Health Services Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Looks Health Services Ltd. is Monika Joshi.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore